Biotechnology Analysis & Statistics in Oceania Countries, June 2013

You might be interested in: biotech, biomedical, biomaterials, more »

» Purchase Premium Reports

1-30 of 55 reports
Global Vaccine Market to 2017 - Market Size, Growth, and Forecasts in Over 70 Countries

Global Vaccine Market to 2017 - Market Size, Growth, and Forecasts in Over 70 Countries

  • $ 2 488
  • Industry report
  • June 2013
  • by MarketSizeInfo

Global Vaccine Market to 2017 - Market Size, Growth and Forecasts in Over 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe, Asia, South America, Czech Republic, South Korea, Philippines, Africa, Australia, Argentina, United States, United Kingdom, Netherlands, Macedonia, Lithuania, Sri Lanka, Singapore, Kazakhstan, Indonesia, Bangladesh, Azerbaijan, South Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Panama, Mexico, Canada, Ukraine, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Belgium, Austria, Vietnam, Thailand, Pakistan, Nepal, Mongolia, Malaysia, Lebanon, Jordan, Japan, India, China, Georgia, Armenia, Sudan, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt, Kyrgyz Republic (kyrgyzstan), Peru, Oman, Iran, North America, Oceania
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company, based in Australia. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. ...

  • Industries : Biological Therapy
  • Countries : Australia
Prima BioMed Limited (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Prima BioMed Limited (PRR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary Prima BioMed Limited (Prima) is a biotechnology company, based in Australia. The company develops anti-cancer therapeutics based on the emerging technology of immunotherapy. Its lead products HPV ...

  • Industries : Biopharmaceutical
  • Countries : Australia
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Immuron Limited (IMC)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Immuron Limited (IMC)

  • $ 250
  • Company report
  • May 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia
Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Benitec Biopharma Limited (BLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary Benitec Biopharma Limited (Benitec), formerly Benitec Limited, is a research focused biotechnology company. The company is indulged in the development of novel therapeutics for the treatment of ...

  • Industries : Biological Therapy
  • Countries : Australia
IMBcom Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

IMBcom Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary IMBcom Pty Ltd (IMBcom) is a biotechnology company, based in Australia. It develops programs that combine research focused on bio informatics, genomics, developmental biology, structural biology ...

  • Industries : Genomics
  • Countries : Australia
Genetic Technologies Limited (Symbol:GTG) SWOT Analysis, Strategy, Revenues and Profits

Genetic Technologies Limited (Symbol:GTG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • March 2013
  • by Global Data

Genetic Technologies Limited (Genetic) is a publicly traded research based life science company. specializes in the field of genetics and genomics. Genetic is engaged in providing diagnostic products ...

  • Industries : Genomics
  • Countries : Australia, United States, Switzerland
Exiqon A/S (Symbol:EXQ) SWOT Analysis, Strategy, Revenues and Profits

Exiqon A/S (Symbol:EXQ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : Denmark, New Zealand, Australia, United States, Italy, South Korea, Japan, China
Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

Cryosite Limited (Symbol:CTE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Australia
NuSep Ltd (Symbol:NSP) SWOT Analysis, Strategy, Revenues and Profits

NuSep Ltd (Symbol:NSP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • March 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : Australia, Singapore, United States
Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2013
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company, based in Australia. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. ...

  • Industries : Biological Therapy
  • Countries : Australia
Biotech Holdings Ltd. (Symbol:BIOHF) SWOT Analysis, Strategy, Revenues and Profits

Biotech Holdings Ltd. (Symbol:BIOHF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • November 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology
  • Countries : Mexico, Canada, United States, Australia, North America, United Kingdom, World
Australia Dental Biomaterial Market Trend Forecast to 2018

Australia Dental Biomaterial Market Trend Forecast to 2018

  • $ 2 100
  • Industry report
  • October 2012
  • by ABMRG

Short Description This research report provides key market trends, market forecasts and competitive scenario of the dental biomaterial in Australia through 2018. The product categories covered in this ...

  • Industries : Biomaterial
  • Countries : Australia
Asia-Pacific Markets for Dental Bone Grafts and Other Biomaterials - Executive Summary

Asia-Pacific Markets for Dental Bone Grafts and Other Biomaterials - Executive Summary

  • $ 295
  • Industry report
  • October 2012
  • by iData Research, Inc.

Scope: This report pertains to a forecast period of 10 years (2008 - 2018) for Japan, South Korea and Australia. Report Contents: Competitor Analysis Identified Strategic Opportunities Market Overview ...

  • Industries : Biomaterial
  • Countries : South Korea, Australia, Japan
Other Immunological Disorders - Pipeline Review, H2 2012

Other Immunological Disorders - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Other Immunological Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Other Immunological Disorders - Pipeline Review, H2 2012', provides an overview of the Other Immunological Disorders ...

  • Industries : Biological Therapy
  • Countries : World, Australia
Biotechnology Market in Australia

Biotechnology Market in Australia

  • $ 980
  • Industry report
  • August 2012
  • by Ibisworld

Growing potential: Market revenue grow s with the return of research funding Biotechnology in Australia Biotechnology is the application of science and technology to living organisms as well as parts, ...

  • Industries : Biopharmaceutical
  • Countries : Australia
Australian Biotechnology Sector: Sector Report

Australian Biotechnology Sector: Sector Report

  • $ 800
  • Industry report
  • July 2012
  • by Daedal Research

This industry profile is an essential tool to help your company gain an in-depth knowledge and competitive advantage in the industry. The profile is an assimilation of insider knowledge, market characteristics ...

  • Industries : Biotechnology
  • Countries : Australia
Australian Biotechnology Market Research

Australian Biotechnology Market Research

  • $ 600
  • Industry report
  • June 2012
  • by Koncept Analytics

This market profile helps to gain an insight into the evolution of the market and competitive dynamics prevalent in the industry . It discusses the significant developments in the market and analyzes the ...

  • Industries : Biotechnology
  • Countries : Australia
Enzymes: Australia : Focus report

Enzymes: Australia : Focus report

  • $ 850
  • Industry report
  • June 2012
  • by Freedonia

Report Description This report discusses enzyme demand in Australia for the years 2005 and 2010, with forecasts for 2015. Topics covered include overview of products; overview of markets; economic trends ...

  • Industries : Biopharmaceutical
  • Countries : Australia
Changmao Biochemical Engineering Co., Lt: Ingredients Company Profile, SWOT & Financial Report

Changmao Biochemical Engineering Co., Lt: Ingredients Company Profile, SWOT & Financial Report

  • $ 125
  • Company report
  • March 2012
  • by Canadean Ltd

Synopsis Canadean's "Changmao Biochemical Engineering Co., Lt: Ingredients Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile ...

  • Industries : Biotechnology
  • Countries : Australia, Japan, China
Sports Nutrition Market Analysis in New Zealand

Sports Nutrition Market Analysis in New Zealand

  • $ 898
  • Industry report
  • March 2012
  • by Euromonitor International

This is evident in 2010's growth of 1%, being lower than the review period CAGR of 4%. Euromonitor International's report offers a comprehensive guide to the size and shape of the industry at a national ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : New Zealand
CSL Limited SWOT

CSL Limited SWOT

  • $ 175
  • Company report
  • February 2012
  • by MarketLine

CSL Limited - SWOT Analysis industry player profile is the essential source for top-level industry player data and information. The market research report examines the firm ?s key business structure and ...

  • Industries : Biopharmaceutical
  • Countries : Australia
Biotechnology Market in Australia

Biotechnology Market in Australia

  • $ 990
  • Industry report
  • January 2012
  • by Ibisworld

This is the first publication of IBISWorld's Biotechnology in Australia Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry Risk Ratings report is a detailed analysis of all risks ...

  • Industries : Biopharmaceutical
  • Countries : Australia
MarketVIEW: Meningococcus serogroup B vaccines

MarketVIEW: Meningococcus serogroup B vaccines

  • $ 10 995
  • Industry report
  • January 2012
  • by VacZine Analytics Group Of Assay Advantage Ltd

With the introduction of vaccines to prevent invasive meningococcal disease due serogroups ACWY, serogroup B now remains a major contributor to current disease burden, especially in Europe where it accounts ...

  • Industries : Biopharmaceutical
  • Countries : World, United Kingdom, New Zealand, United States, Russian Federation
Delving into Stem Cell Research and its Potential

Delving into Stem Cell Research and its Potential

  • $ 350
  • Industry report
  • January 2012
  • by Aruvian's R'search

Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. ...

  • Industries : Biological Therapy
  • Countries : World, Australia, United States, United Kingdom, Europe, Canada, Germany, Japan, Israel, China
Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment

  • $ 3 500
  • Industry report
  • December 2011
  • by GBI Research

Oncology Devices Market to 2017 - Improved Efficiency, Shorter Treatment Times and Cost-Effectiveness to Boost the Brachytherapy Devices Segment Summary GBI Research's report, ?Oncology Devices Market ...

  • Industries : Biological Therapy
  • Countries : World, Australia, Brazil, Canada, Spain, Italy, Germany, Japan, India, China, France, United States, United Kingdom, Europe, Oceania, Asia, South America, North America
HEXIMA LIMITED (Symbol:HXL) SWOT Analysis, Strategy, Revenues and Profits

HEXIMA LIMITED (Symbol:HXL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : Australia
RegeneRx Biopharmaceuticals, Inc. (Symbol:RGN) SWOT Analysis, Strategy, Revenues and Profits

RegeneRx Biopharmaceuticals, Inc. (Symbol:RGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 250
  • Company report
  • September 2011
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia, United States
Actelion Ltd SWOT

Actelion Ltd SWOT

  • $ 175
  • Company report
  • August 2011
  • by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Actelion is a biopharmaceutical industry player focused ...

  • Industries : Biopharmaceutical
  • Countries : Switzerland, Australia, Brazil, Canada, Japan, World, Europe, United States
Asia Pacific Biotechnology Market (2008-2012)

Asia Pacific Biotechnology Market (2008-2012)

  • $ 1 600
  • Industry report
  • June 2011
  • by RNCOS

The Asia Pacific biotechnology market is one with immense potential, which can be tapped through investments driving the infrastructure and R&D in the sector. Investments in the past have been the main ...

  • Industries : Biotechnology
  • Countries : Asia, South Korea, India, New Zealand, Japan, Australia, Singapore, Malaysia, China, World, Oceania, Taiwan

» Download Public Reports

About 300 reports
Australia: Country Brief, 2012, focus on Biotechnology

Australia: Country Brief, 2012, focus on Biotechnology

  • Country report
  • October 2012
  • 2 pages

... Is commercialising vitrogro ecm, a technology created by cell biology, tissue engineering and protein engineering experts at the institute of health and biomedical innovation at the queensland university ...


Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.